Search

Author/Creator Hofman, Michael S

1. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Issue 9 (September 2019)

Authors:
Calais, Jeremie; Ceci, Francesco; Eiber, Matthias; Hope, Thomas A; Hofman, Michael S; Rischpler, Christoph; Bach-Gansmo, Tore; Nanni, Cristina; Savir-Baruch, Bital; Elashoff, David; Grogan, Tristan; Dahlbom, Magnus; Slavik, Roger; Gartmann, Jeannine; Nguyen, Kathleen; Lok, Vincent; Jadvar, Hossei...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 9(2019)
Page Start:
1286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study. Issue 6 (June 2018)

Authors:
Hofman, Michael S; Violet, John; Hicks, Rodney J; Ferdinandus, Justin; Thang, Sue Ping; Akhurst, Tim; Iravani, Amir; Kong, Grace; Ravi Kumar, Aravind; Murphy, Declan G; Eu, Peter; Jackson, Price; Scalzo, Mark; Williams, Scott G; Sandhu, Shahneen
Journal:
Lancet oncology
Issue:
Volume 19:Issue 6(2018)
Page Start:
825
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial. Issue 10276 (27th February 2021)

Authors:
Hofman, Michael S; Emmett, Louise; Sandhu, Shahneen; Iravani, Amir; Joshua, Anthony M; Goh, Jeffrey C; Pattison, David A; Tan, Thean Hsiang; Kirkwood, Ian D; Ng, Siobhan; Francis, Roslyn J; Gedye, Craig; Rutherford, Natalie K; Weickhardt, Andrew; Scott, Andrew M; Lee, Sze-Ting; Kwan, Edmond M; Az...
Journal:
Lancet
Issue:
Volume 397:Issue 10276(2021)
Page Start:
797
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Comparison of dual-energy CT with positron emission tomography for lung perfusion imaging in patients with non-small cell lung cancer. (7th February 2023)

Authors:
Gaudreault, Mathieu; Korte, James; Bucknell, Nicholas; Jackson, Price; Sakyanun, Pitchaya; McIntosh, Lachlan; Woon, Beverley; Buteau, James P; Hofman, Michael S; Mulcahy, Tony; Kron, Tomas; Siva, Shankar; Hardcastle, Nicholas
Journal:
Physics in medicine & biology
Issue:
Volume 68:Number 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Nodal metabolic tumour volume on baseline 18F‐FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative‐intent chemoradiotherapy/radiotherapy. Issue 6 (28th July 2021)

Authors:
Alipour, Ramin; Bucknell, Nick; Bressel, Mathias; Everitt, Sarah; MacManus, Michael; Siva, Shankar; Hofman, Michael S; Akhurst, Tim; Hicks, Rodney J; Iravani, Amir
Journal:
Journal of medical imaging and radiation oncology
Issue:
Volume 65:Issue 6(2021)
Page Start:
748
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study. Issue 8 (August 2021)

Authors:
Gafita, Andrei; Calais, Jeremie; Grogan, Tristan R; Hadaschik, Boris; Wang, Hui; Weber, Manuel; Sandhu, Shahneen; Kratochwil, Clemens; Esfandiari, Rouzbeh; Tauber, Robert; Zeldin, Anna; Rathke, Hendrik; Armstrong, Wesley R; Robertson, Andrew; Thin, Pan; D'Alessandria, Calogero; Rettig, Matthew B;...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 8(2021)
Page Start:
1115
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Issue 10231 (11th April 2020)

Authors:
Hofman, Michael S; Lawrentschuk, Nathan; Francis, Roslyn J; Tang, Colin; Vela, Ian; Thomas, Paul; Rutherford, Natalie; Martin, Jarad M; Frydenberg, Mark; Shakher, Ramdave; Wong, Lih-Ming; Taubman, Kim; Ting Lee, Sze; Hsiao, Edward; Roach, Paul; Nottage, Michelle; Kirkwood, Ian; Hayne, Dickon; Lin...
Journal:
Lancet
Issue:
Volume 395:Issue 10231(2020)
Page Start:
1208
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial. Issue 11 (November 2022)

Authors:
Buteau, James P; Martin, Andrew J; Emmett, Louise; Iravani, Amir; Sandhu, Shahneen; Joshua, Anthony M; Francis, Roslyn J; Zhang, Alison Y; Scott, Andrew M; Lee, Sze-Ting; Azad, Arun A; McJannett, Margaret M; Stockler, Martin R; Williams, Scott G; Davis, Ian D; Hofman, Michael S; Akhurst, Tim; Ali...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 11(2022)
Page Start:
1389
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗